Escalade Inc: Form 10-K for the period ended Dec 27, 2014
Filed with the SEC on Feb 25, 2015 and accepted by EDGAR at Feb 25, 2015, 14:33 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2014-12-27. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2014-10-05 to 2014-12-27 | $40.6m | us-gaap:SalesRevenueGoodsNet |
| Revenue | 12 months2013-12-29 to 2014-12-27 | $158.8m | us-gaap:Revenues |
| Cost of revenue | 12 months2013-12-29 to 2014-12-27 | $96.9m | us-gaap:CostOfGoodsSold |
| Research and development | 12 months2013-12-29 to 2014-12-27 | $1.7m | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2013-12-29 to 2014-12-27 | $22.9m | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 3 months2014-10-05 to 2014-12-27 | $4.0m | us-gaap:OperatingIncomeLoss |
| Operating income | 12 months2013-12-29 to 2014-12-27 | $15.5m | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2013-12-29 to 2014-12-27 | $447.0k | us-gaap:InterestExpense |
| Income tax | 12 months2013-12-29 to 2014-12-27 | $6.4m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2014-10-05 to 2014-12-27 | $4.0m | us-gaap:NetIncomeLoss |
| Net income | 12 months2013-12-29 to 2014-12-27 | $11.8m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2014-10-05 to 2014-12-27 | $0.29 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 12 months2013-12-29 to 2014-12-27 | $0.84 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2014-10-05 to 2014-12-27 | $0.29 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 12 months2013-12-29 to 2014-12-27 | $0.85 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2013-12-29 to 2014-12-27 | 14,067,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2013-12-29 to 2014-12-27 | $18.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2013-12-29 to 2014-12-27 | $2.7m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2013-12-29 to 2014-12-27 | $5.3m | us-gaap:PaymentsOfDividends |
| Cash and equivalents | At period end2014-12-27 | $3.2m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2014-12-27 | $68.9m | us-gaap:AssetsCurrent |
| Total assets | At period end2014-12-27 | $127.9m | us-gaap:Assets |
| Current liabilities | At period end2014-12-27 | $31.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2014-12-27 | $38.1m | us-gaap:Liabilities |
| Long-term debt | At period end2014-12-27 | $3.4m | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2014-12-27 | $1.6m | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2014-12-27 | $17.8m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2014-12-27 | $89.8m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001144204-15-011858. Last ingested by Listed: Nov 11, 2026, 02:51 ET. Listed shows no prices and gives no investment advice.